purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Livestock Vaccines Market Overview
1.1 Product Overview and Scope of Livestock Vaccines
1.2 Livestock Vaccines Segment by Type
1.2.1 Global Livestock Vaccines Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Foot and Mouth Disease Vaccine
1.2.3 Pig Ring Vaccine
1.2.4 Bird Flu Vaccine
1.2.5 Porcine Blue Ear Vaccine
1.2.6 Swine Fever Vaccine
1.3 Livestock Vaccines Segment by Application
1.3.1 Global Livestock Vaccines Sales Comparison by Application: (2022-2028)
1.3.2 Pig
1.3.3 Cattle and Sheep
1.3.4 Others
1.4 Global Livestock Vaccines Market Size Estimates and Forecasts
1.4.1 Global Livestock Vaccines Revenue 2017-2028
1.4.2 Global Livestock Vaccines Sales 2017-2028
1.4.3 Livestock Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 Livestock Vaccines Market Competition by Manufacturers
2.1 Global Livestock Vaccines Sales Market Share by Manufacturers (2017-2022)
2.2 Global Livestock Vaccines Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Livestock Vaccines Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Livestock Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Livestock Vaccines Market Competitive Situation and Trends
2.5.1 Livestock Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Livestock Vaccines Players Market Share by Revenue
2.5.3 Global Livestock Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Livestock Vaccines Retrospective Market Scenario by Region
3.1 Global Livestock Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Livestock Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Livestock Vaccines Market Facts & Figures by Country
3.3.1 North America Livestock Vaccines Sales by Country
3.3.2 North America Livestock Vaccines Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Livestock Vaccines Market Facts & Figures by Country
3.4.1 Europe Livestock Vaccines Sales by Country
3.4.2 Europe Livestock Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Livestock Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Livestock Vaccines Sales by Region
3.5.2 Asia Pacific Livestock Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Livestock Vaccines Market Facts & Figures by Country
3.6.1 Latin America Livestock Vaccines Sales by Country
3.6.2 Latin America Livestock Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Livestock Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Livestock Vaccines Sales by Country
3.7.2 Middle East and Africa Livestock Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Livestock Vaccines Historic Market Analysis by Type
4.1 Global Livestock Vaccines Sales Market Share by Type (2017-2022)
4.2 Global Livestock Vaccines Revenue Market Share by Type (2017-2022)
4.3 Global Livestock Vaccines Price by Type (2017-2022)
5 Global Livestock Vaccines Historic Market Analysis by Application
5.1 Global Livestock Vaccines Sales Market Share by Application (2017-2022)
5.2 Global Livestock Vaccines Revenue Market Share by Application (2017-2022)
5.3 Global Livestock Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck Livestock Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Boehringer Ingelheim Livestock Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Ceva
6.3.1 Ceva Corporation Information
6.3.2 Ceva Description and Business Overview
6.3.3 Ceva Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Ceva Livestock Vaccines Product Portfolio
6.3.5 Ceva Recent Developments/Updates
6.4 Zoetis
6.4.1 Zoetis Corporation Information
6.4.2 Zoetis Description and Business Overview
6.4.3 Zoetis Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Zoetis Livestock Vaccines Product Portfolio
6.4.5 Zoetis Recent Developments/Updates
6.5 Vaxxinova?
6.5.1 Vaxxinova? Corporation Information
6.5.2 Vaxxinova? Description and Business Overview
6.5.3 Vaxxinova? Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Vaxxinova? Livestock Vaccines Product Portfolio
6.5.5 Vaxxinova? Recent Developments/Updates
6.6 Elanco
6.6.1 Elanco Corporation Information
6.6.2 Elanco Description and Business Overview
6.6.3 Elanco Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Elanco Livestock Vaccines Product Portfolio
6.6.5 Elanco Recent Developments/Updates
6.7 QYH Biotech Co., Ltd
6.6.1 QYH Biotech Co., Ltd Corporation Information
6.6.2 QYH Biotech Co., Ltd Description and Business Overview
6.6.3 QYH Biotech Co., Ltd Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 QYH Biotech Co., Ltd Livestock Vaccines Product Portfolio
6.7.5 QYH Biotech Co., Ltd Recent Developments/Updates
6.8 Pulike
6.8.1 Pulike Corporation Information
6.8.2 Pulike Description and Business Overview
6.8.3 Pulike Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Pulike Livestock Vaccines Product Portfolio
6.8.5 Pulike Recent Developments/Updates
6.9 Phibro Animal Health Corporation
6.9.1 Phibro Animal Health Corporation Corporation Information
6.9.2 Phibro Animal Health Corporation Description and Business Overview
6.9.3 Phibro Animal Health Corporation Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Phibro Animal Health Corporation Livestock Vaccines Product Portfolio
6.9.5 Phibro Animal Health Corporation Recent Developments/Updates
6.10 JinYu Biotechnology
6.10.1 JinYu Biotechnology Corporation Information
6.10.2 JinYu Biotechnology Description and Business Overview
6.10.3 JinYu Biotechnology Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.10.4 JinYu Biotechnology Livestock Vaccines Product Portfolio
6.10.5 JinYu Biotechnology Recent Developments/Updates
6.11 Harbin Pharmaceutical Group
6.11.1 Harbin Pharmaceutical Group Corporation Information
6.11.2 Harbin Pharmaceutical Group Livestock Vaccines Description and Business Overview
6.11.3 Harbin Pharmaceutical Group Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Harbin Pharmaceutical Group Livestock Vaccines Product Portfolio
6.11.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.12 MEVAC
6.12.1 MEVAC Corporation Information
6.12.2 MEVAC Livestock Vaccines Description and Business Overview
6.12.3 MEVAC Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.12.4 MEVAC Livestock Vaccines Product Portfolio
6.12.5 MEVAC Recent Developments/Updates
6.13 Venky's
6.13.1 Venky's Corporation Information
6.13.2 Venky's Livestock Vaccines Description and Business Overview
6.13.3 Venky's Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Venky's Livestock Vaccines Product Portfolio
6.13.5 Venky's Recent Developments/Updates
6.14 Japfa Comfeed Indonesia
6.14.1 Japfa Comfeed Indonesia Corporation Information
6.14.2 Japfa Comfeed Indonesia Livestock Vaccines Description and Business Overview
6.14.3 Japfa Comfeed Indonesia Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Japfa Comfeed Indonesia Livestock Vaccines Product Portfolio
6.14.5 Japfa Comfeed Indonesia Recent Developments/Updates
6.15 Nisseiken
6.15.1 Nisseiken Corporation Information
6.15.2 Nisseiken Livestock Vaccines Description and Business Overview
6.15.3 Nisseiken Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Nisseiken Livestock Vaccines Product Portfolio
6.15.5 Nisseiken Recent Developments/Updates
6.16 Hile
6.16.1 Hile Corporation Information
6.16.2 Hile Livestock Vaccines Description and Business Overview
6.16.3 Hile Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Hile Livestock Vaccines Product Portfolio
6.16.5 Hile Recent Developments/Updates
6.17 Hester Biosciences
6.17.1 Hester Biosciences Corporation Information
6.17.2 Hester Biosciences Livestock Vaccines Description and Business Overview
6.17.3 Hester Biosciences Livestock Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Hester Biosciences Livestock Vaccines Product Portfolio
6.17.5 Hester Biosciences Recent Developments/Updates
7 Livestock Vaccines Manufacturing Cost Analysis
7.1 Livestock Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Livestock Vaccines
7.4 Livestock Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Livestock Vaccines Distributors List
8.3 Livestock Vaccines Customers
9 Livestock Vaccines Market Dynamics
9.1 Livestock Vaccines Industry Trends
9.2 Livestock Vaccines Market Drivers
9.3 Livestock Vaccines Market Challenges
9.4 Livestock Vaccines Market Restraints
10 Global Market Forecast
10.1 Livestock Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Livestock Vaccines by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Livestock Vaccines by Type (2023-2028)
10.2 Livestock Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Livestock Vaccines by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Livestock Vaccines by Application (2023-2028)
10.3 Livestock Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Livestock Vaccines by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Livestock Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer